The aim of the invention is to maximize the efficacy of, minimize the incidence of side effects of, and improve the storage stability of eye drops containing: a peptide (sssr), whose amino acid sequence is represented by ser-ser-arg or its pharmacologically acceptable sa and a peptide (fglm), whose amino acid sequence is represented by phe-gly-leu-met-nh2, or its pharmacologically acceptable salt. the concentration ratio between sssr or its pharmacologically acceptable salt and fglm or its pharmacologically acceptable salt is from 1/15 to 1/50. the concentration of sssr or its pharmacologically acceptable salt is between 0.001% and 0.3% (w / v) and the concentration of fglm or its pharmacologically acceptable salt is between 0.015% and 1.5% (w / v) v). the ph of the eye drops is kept between 2.5 and 6.5.
展开▼
